By: Ellen Baron, PhD and Oded Ben-Joseph, PhD, MBA
Big guns may have been fired up this week in the financing world with 6 of 12 Biotech IPOs debuting and raising more than $460M dollars.
This figure however is dwarfed by the value of Merger & Acquisitions announced or offers made within healthcare during June to date — and the month isn’t quite over yet!
These deals continue a string of M&A deals announced since the start of 2018, which is headed for record highs — both in the number of deals and the size of those transactions. Overall, healthcare M&A values surged globally during 2017, rising 27% to $332 billion, while the deal count increased 16%. That very robust activity looks to be continuing in 2018.
We strongly believe that despite the recent activity in the public markets, M&A is a far superior path to return on capital for investors — and these numbers support our views.
As a result, we here at Outcome are looking forward to a busy M&A calendar for the remainder of 2018!
Federal Data Systems Has Received an Investment from McNally Capital August 30, 2018, Reston, VA Federal Data Systems, Inc (FedData) has received an investment from McNally Capital. FedData is a leader in providing critical infrastructure and services to the Department of Defense and the National Intelligence Community, and a provider of threat reduction and counterintelligence […]Read More
Outcome Capital Announces Digital Intelligence Systems Has Acquired Xtreme Consulting Group June 18, 2018, Reston, VA and Boston, MA. Outcome Capital, an investment banking firm that serves middle market growth companies in the life science and technology segments, is pleased to announce that its client, Digital Intelligence Systems (DISYS), a global staffing and IT consulting firm, […]Read More